Showing 191-200 of 3458 results for "".
Alexa Boer Kimball, MD
https://practicaldermatology.com/topics/psoriasis/alexa-boer-kimball-md/22937/Estrogen and Skin: What Can We Do
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/estrogen-and-skin-what-can-we-do/20123/There’s accumulated evidence that depletion of estrogen with age contributes to the visible signs of skin aging. But dermatologists haven’t had many treatment options—until now. Joel L. Cohen, MD addresses the latest developments in care for estrogen deficient skin.UV Talk: Men and Women
https://practicaldermatology.com/topics/skin-cancer-photoprotection/uv-talk-men-and-women/18695/Talk to every patient about UV avoidance, but tailor your patient to each patient's needs and behavior, says Joel L. Cohen, MD. Consider the patient's sex when making recommendations. Watch now to get Dr. Cohen's tip for endurance athletes.New and Emerging Treatments in Aesthetic Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-and-emerging-treatments-in-aesthetic-dermatology/18819/Joel Cohen, MD provides an update on innovative treatments in aesthetic dermatology that have really blossomed in the last year, such as combination non-ablative and ablative fractional and bipolar radiofrequency. He also says there are now great modalities to treat the whole patient—from the neck,Systemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseInjectable Safety
https://practicaldermatology.com/conferences/maui-derm-2022/injectable-safety/20272/When using fillers in the face, it's important to think about the anatomy beneath the skin, says Joel L. Cohen, MD. He stresses the importance of going beyond text book and cartoon drawings of anatomy, which might not be complete, and thinking about cadaver studies to ensure a complete understandingA Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReToxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.New Toxin Textbook Hits Shelves
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-toxin-textbook-hits-shelves/18321/Available at Wiley-Blackwell and on Amazon.com, “Botulinum Toxins: Cosmetic and Clinical Applications” offers up-to-date info on neuromodulators in the US and abroad, along with tips on how to use them on the face and body. Joel Cohen, MD shares details about his new textbook.